Related Experiment Video
Updated: Jul 5, 2025
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.4K
Evolution of Mechanical Circulatory Support for advanced heart failure
Cathrine M Moeller1, Andrea Fernandez Valledor1, Daniel Oren1
1Division of Cardiology, Department of Medicine, Advanced Cardiac Care, Columbia University Irving Medical Center, NY, USA.
Progress in Cardiovascular Diseases
|January 19, 2024
Summary
Advancements in Left Ventricular Assist Device (LVAD) therapy, particularly the HeartMate 3, have improved survival and quality of life for advanced heart failure patients. Ongoing innovations promise more personalized and effective treatments.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Advanced heart failure necessitates mechanical circulatory support.
- Left Ventricular Assist Devices (LVADs) have evolved significantly.
- Continuous-flow LVADs, like HeartMate 3, offer improved outcomes.
Purpose of the Study:
- To review advancements in LVAD therapy.
- To discuss the evolving role of LVADs (bridge-to-transplantation and destination therapy).
- To highlight progress in reducing complications and improving patient quality of life.
Main Methods:
- Review of current literature on LVAD technology and clinical outcomes.
- Analysis of trends in LVAD application and policy.
- Exploration of emerging technologies for complication management and outcome prediction.
Main Results:
- Continuous-flow LVADs, especially HeartMate 3, show improved survival and reduced hemocompatibility-related adverse events.
- New strategies for predicting outcomes and managing complications (e.g., infections, driveline issues) are emerging.
- Innovative approaches like hemodynamic ramp tests and remote monitoring enhance patient care.
Conclusions:
- LVAD therapy has significantly improved outcomes for advanced heart failure.
- Future innovations aim for automated, personalized LVAD management.
- Ongoing research promises to revolutionize heart failure treatment.
